TY - JOUR
T1 - Effects of nimodipine on the behavioral sequalae of experimental status epilepticus in prepubescent rats
AU - Mikati, Mohamad A.
AU - Holmes, Gregory L.
AU - Werner, Suzanne
AU - Bakkar, Nadine
AU - Carmant, Lionel
AU - Liu, Zhao
AU - Stafstrom, Carl E.
N1 - Funding Information:
This work was supported by the Wark Epilepsy Research Fund and the URB Grant Program (Fund 17996074524) to M.A.M. and by the Mental Retardation Research Center from NIH (2P30HD18655) and a grant from NINDS (NS27984) to G.L.H.
PY - 2004/4
Y1 - 2004/4
N2 - Objective. The goal of this study was to investigate the potential protective effects of nimodipine (ND), a calcium channel blocker, on the acute manifestations and long-term behavioral sequalae of experimental status epilepticus (SE). Methods. Three groups of Postnatal Day (P) 35 rats undergoing kainic acid (KA)-induced SE were injected with phenobarbital (PB) and/or ND, and were subsequently compared with rats injected with KA alone and normal control rats. Behavioral parameters were assessed by the Morris water maze, open field, and handling tests at P125-P135. Acute seizures and spontaneous recurrent seizures (SRS) were assessed by videotape techniques. Results. PB reduced the severity of SE acutely, and protected completely against subsequent long-term SRS, memory impairment, and hyperactivity, and partially against aggressivity. ND alone had no effect on acute seizure activity, but did protect against subsequent SRS and memory impairment, and partially against aggressivity. When administered together, PB and ND had effects similar to those seen with PB alone. However, in addition, and unlike the PB- and ND-alone groups, the PB-ND group was completely protected against KA-induced increased aggressivity. Conclusions. Activation of L-type calcium channels contributes to the long-term behavioral sequalae of KA-induced SE, but is not essential for the development and maintenance of SE. ND has protective effects in SE when given alone or in conjunction with a traditional antiepileptic drug. Calcium channel blockers should be further investigated as add-on protective agents in models of SE and possibly in clinical trials.
AB - Objective. The goal of this study was to investigate the potential protective effects of nimodipine (ND), a calcium channel blocker, on the acute manifestations and long-term behavioral sequalae of experimental status epilepticus (SE). Methods. Three groups of Postnatal Day (P) 35 rats undergoing kainic acid (KA)-induced SE were injected with phenobarbital (PB) and/or ND, and were subsequently compared with rats injected with KA alone and normal control rats. Behavioral parameters were assessed by the Morris water maze, open field, and handling tests at P125-P135. Acute seizures and spontaneous recurrent seizures (SRS) were assessed by videotape techniques. Results. PB reduced the severity of SE acutely, and protected completely against subsequent long-term SRS, memory impairment, and hyperactivity, and partially against aggressivity. ND alone had no effect on acute seizure activity, but did protect against subsequent SRS and memory impairment, and partially against aggressivity. When administered together, PB and ND had effects similar to those seen with PB alone. However, in addition, and unlike the PB- and ND-alone groups, the PB-ND group was completely protected against KA-induced increased aggressivity. Conclusions. Activation of L-type calcium channels contributes to the long-term behavioral sequalae of KA-induced SE, but is not essential for the development and maintenance of SE. ND has protective effects in SE when given alone or in conjunction with a traditional antiepileptic drug. Calcium channel blockers should be further investigated as add-on protective agents in models of SE and possibly in clinical trials.
KW - Kainic acid
KW - Nimodipine
KW - Phenobarbital
KW - Status epilepticus
UR - http://www.scopus.com/inward/record.url?scp=1842687405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1842687405&partnerID=8YFLogxK
U2 - 10.1016/j.yebeh.2003.12.002
DO - 10.1016/j.yebeh.2003.12.002
M3 - Article
C2 - 15123017
AN - SCOPUS:1842687405
SN - 1525-5050
VL - 5
SP - 168
EP - 174
JO - Epilepsy and Behavior
JF - Epilepsy and Behavior
IS - 2
ER -